Using Immune-Related lncRNA Signature for Prognosis and Response to Immunotherapy in Cutaneous Melanoma

BACKGROUND: Cutaneous melanoma is a highly malignant skin tumor, and most patients have a poor prognosis. In recent years, immunotherapy has assumed an important role in the treatment of advanced cutaneous melanoma, but only a small percentage of patients benefit from immunotherapy. A growing number...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Ling, Wu, Pingfan, Zhao, Xiaowen, Jin, Xiaojie, Wang, Jingjing, Shi, Yuxiang, Yang, Xiaojing, She, Yali, Li, Yaling, Li, Changtian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518697/
https://www.ncbi.nlm.nih.gov/pubmed/34675614
http://dx.doi.org/10.2147/IJGM.S335266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518697/
https://www.ncbi.nlm.nih.gov/pubmed/34675614
http://dx.doi.org/10.2147/IJGM.S335266

Ejemplares similares